Abstract
Oral DiseasesEarly View ERRATUMFree Access First published: 26 June 2022 https://doi.org/10.1111/odi.14263AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat In the article by Suga et al (1), the author comments to a Letter to the Editor should have been published as supporting information. The documents are now available in the online version of the article. We apologize for these errors. REFERENCE 1Suga, T., Tu, T. T. H., Nagamine, T., & Toyofuku, A. (2022). Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment. Oral Diseases, 28, 846– 847. https://doi.org/10.1111/odi.13776Wiley Online LibraryPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
